Cigna Group
XMUN:CGN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240.3
338.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cigna Group
Cash Equivalents
Cigna Group
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cigna Group
XMUN:CGN
|
Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash Equivalents
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash Equivalents
$764m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash Equivalents
$6.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
Cigna Corp
NYSE:CI
|
Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
10%
|
|
Cigna Group
Glance View
Cigna Group, a prominent global health service company, has carved out a significant niche in the ever-evolving landscape of healthcare and insurance. With roots tracing back to the 1980s, Cigna's mission is to enhance the health, wellness, and peace of mind for its customers through a diverse array of products and services. Today, the company serves millions of customers worldwide, offering a robust portfolio that includes health insurance, disability, life insurance, and managed care solutions. As the healthcare landscape becomes increasingly complex, Cigna stands out through its innovative approach to care coordination and a focus on preventive solutions that address not just the symptoms but the underlying factors affecting health. From an investor's perspective, Cigna Group presents a compelling opportunity. The company has demonstrated strong financial stability and growth potential, underpinned by strategic acquisitions, like the significant purchase of Express Scripts, which expanded its capabilities in pharmacy benefits management. Cigna's commitment to integrating digital technology into healthcare services, alongside its focus on value-based care, positions it well amidst rising healthcare costs and an aging population that demands more personalized care solutions. With a solid track record of revenue growth, consistent shareholder returns, and a forward-thinking leadership team, Cigna Group offers investors a unique blend of resilience, adaptability, and long-term value in an increasingly important sector.
See Also
What is Cigna Group's Cash Equivalents?
Cash Equivalents
5.9B
USD
Based on the financial report for Sep 30, 2024, Cigna Group's Cash Equivalents amounts to 5.9B USD.
What is Cigna Group's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash Equivalents growth was -31%. The average annual Cash Equivalents growth rates for Cigna Group have been 19% over the past three years , 5% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
